What is Onpattro?

Onpattro (patisiran) is an FDA-approved prescription medication used to treat polyneuropathy in adults with hereditary transthyretin-mediated amyloidosis (hATTR). hATTR is a rare genetic condition where misfolded transthyretin (TTR) proteins accumulate as amyloid deposits in various tissues and organs, leading to nerve damage and other complications. Onpattro works by utilizing small interfering RNA (siRNA) to reduce the production of both mutant and wild-type TTR proteins, thereby decreasing amyloid deposits and alleviating symptoms associated with polyneuropathy.

Side Effects

Upper respiratory tract infection

Administration

Duration

90 minutes

Cycle

Every 3 weeks

Conditions Onpattro Treats

See what other infusions we offer

Information coming soon...

Check out our other treatments or contact us with any questions

Why Patients Choose Infusion to Recieve Their Onpattro Treatment

Infusion Specialists care for patients with complex chronic conditions by redefining the infusion therapy experience. They focus on patient-centered care that transcends traditional medical infusion treatments.

Redefine your care experience

Private Suites

Leather recliners and space for guests

On your Schedule

Local Centers offer flexible scheduling, including early morning, evenings, and weekends

Goodbye Waiting

Greeted by name at check-in, patient suites are always ready upon arrival

Sit Back and Relax

In-room streaming options and plenty of snacks